Pulmonary Hypertension Association
The Pulmonary Hypertension Association (PHA) is an American non-profit organization based in Silver Spring, Maryland.
Organization
PHA is a member organization of the Alliance for a Stronger FDA.1)
Funding
Corporate committee
Jim Serpico of Bayer is chair of PHA's corporate committee. Committee member companies also provide funding to PHA, based on wording from earlier annual reports.
Members include:7) 8) 9) 10) 11) 12) 13)
- Actelion Pharmaceuticals (former)
- Altavant Sciences (former)
- AllianceRx Walgreens Pharmacy (former)
- Ballerophon Therapeutics (former)
- Biogen (former)
- BriovaRx (former)
- Complexa (former)
- CoTherix (former)
- CuraScript Therapeutics (former)
- CVS Caremark (former)
- Eiger BioPharmaceuticals (former)
- Eli Lilly (former)
- Encysive Pharmaceuticals (former)
- Gilead Sciences (former)
- GlaxoSmithKline (former)
- Medtronic (former)
- Myogen (former)
- Novartis (former)
- Pfizer (former)
- Pharmaceutical Research and Manufacturers of America (PhRMA - former)
- Reata Pharmaceuticals (former)
- Shields Health Solutions (former)
- SteadyMed Therapeutics (former)
- Teva Pharmaceuticals (former)
External links
1)
List of Members. (2022, March 4). Alliance for a Stronger FDA. https://archive.ph/Veeqd
2)
Wetherill, J. Sponsors. Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416215850/https://phassociation.org/aboutpha/sponsors/
3)
Wetherill, J. Annual Report - 2021. Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416223004/https://phassociation.org/accountability/annual-report-2021/
4)
Granato, M. J., & Brunetti, C. (2021, September 14). PHA Annual Report 2020 by Pulmonary Hypertension Association. Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416231442/https://issuu.com/phassociation/docs/pha-2020_annual_report_issuu_final
5)
Wong, B. A., & Fagan, K. A. (2020, August 6). PHA 2019 Annual Report. Issuu; Pulmonary Hypertension Association. https://web.archive.org/web/20230416232200/https://issuu.com/phassociation/docs/pha_2019_annual_report_-_pages
6)
McGoon, M. D. Annual Report 2007. Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824100439/http://www.phassociation.org/document.doc?id=47
7)
Corporate Committee. Pulmonary Hypertension Association. Retrieved April 16, 2023, from https://web.archive.org/web/20230416220234/https://phassociation.org/corporate-committee/
8)
Corporate Committee. Pulmonary Hypertension Association. Retrieved July 1, 2017, from http://archive.today/2017.07.01-171109/https://phassociation.org/corporate-committee/
9)
Corporate Committee. Pulmonary Hypertension Association. Retrieved August 20, 2019, from https://web.archive.org/web/20190820134625/https://phassociation.org/corporate-committee/
10)
McLaughlin, V., & Aldrighetti, R. Annual Report 2012. Pulmonary Hypertension Association. Retrieved November 29, 2022, from https://web.archive.org/web/20221129110205/https://phassociation.org/wp-content/uploads/2017/02/PHA-Annual-Report-2012.pdf
11)
, 12)
Hicks, C. Annual Report 2009. Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824114725/http://www.phassociation.org/document.doc?id=46
13)
Hicks, C., & Aldrighetti, R. Annual Report 2008. Pulmonary Hypertension Association. Retrieved August 24, 2014, from https://web.archive.org/web/20140824091525/http://www.phassociation.org/document.doc?id=28